Cargando…

Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease

Introduction: Hepatocellular carcinoma (HCC) is increasing in incidence in the UK and globally. Liver cirrhosis is the common cause for developing HCC. The common reasons for liver cirrhosis are viral hepatitis C (HCV), viral hepatitis B and alcohol. However, HCC caused by non-alcoholic fatty liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Than, Nwe Ni, Ghazanfar, Anwar, Hodson, James, Tehami, Nadeem, Coldham, Chris, Mergental, Hynek, Manas, Derek, Shah, Tahir, Newsome, Philip N., Reeves, Helen, Shetty, Shishir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444673/ https://www.ncbi.nlm.nih.gov/pubmed/27634970 http://dx.doi.org/10.1093/qjmed/hcw151

Ejemplares similares

AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease
por: Beale, Gary, et al.
Publicado: (2008)

Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol
por: Than, Nwe Ni, et al.
Publicado: (2016)

Pathogenesis of non-alcoholic fatty liver disease
por: Dowman, J. K., et al.
Publicado: (2010)

Pushing the Limits: Machine Preservation of the Liver as a Tool to Recondition High-Risk Grafts
por: Boteon, Yuri L., et al.
Publicado: (2018)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

The Importance of the Fatty Acid Transporter L-Carnitine in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Savic, Dragana, et al.
Publicado: (2020)

Post-ERCP Pancreatitis: Prevention, Diagnosis and Management
por: Cahyadi, Oscar, et al.
Publicado: (2022)

Biomarkers of Liver Injury during Transplantation in an Era of Machine Perfusion
por: Bhogal, Ricky H., et al.
Publicado: (2020)

Reply to ‘Hypothermic machine perfusion before viability testing of previously discarded human livers’
por: Mergental, Hynek, et al.
Publicado: (2021)

Corrigendum to “Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy”
por: Than, Nwe Ni, et al.
Publicado: (2016)

Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy
por: Than, Nwe Ni, et al.
Publicado: (2016)

An Unusual Case of Hematochezia
por: Payne, Anna, et al.
Publicado: (2020)

Comparable Overall Survival in Patients with Hepatocellular Carcinoma Diagnosed within and outside a Surveillance Programme: The Potential Impact of Liver Cirrhosis
por: Faulkes, Rosemary E., et al.
Publicado: (2023)

The potential of PIVKA-II as a treatment response biomarker in hepatocellular carcinoma: a prospective United Kingdom cohort study
por: Sagar, Vandana M., et al.
Publicado: (2021)

Effect of cytochrome P450 3A5 polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients
por: Htun, Yi Yi, et al.
Publicado: (2020)

Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
por: O’Rourke, Joanne Marie, et al.
Publicado: (2018)

Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients
por: Than, Nwe Ni, et al.
Publicado: (2016)

Ex Situ Arterial Reconstruction During Normothermic Perfusion of the Liver
por: Nasralla, David, et al.
Publicado: (2020)

Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges
por: Ahmad, Muhammad Imran, et al.
Publicado: (2022)

Poor correlation of 2D shear wave elastography and transient elastography in Fontan‐associated liver disease: A head‐to‐head comparison
por: Gill, Madeleine, et al.
Publicado: (2023)

Management of infected post-pancreatic resection fluid collections under endoscopic ultrasound guidance using lumen apposing metal stent: A case series and review of the literature
por: Chhabra, Puneet, et al.
Publicado: (2021)

Imaging of non alcoholic fatty liver disease: A road less travelled
por: Singh, Divya, et al.
Publicado: (2013)

Targeting inflammasome pathway by polyphenols as a strategy for pancreatitis, gastrointestinal and liver diseases management: an updated review
por: Nani, Abdelhafid, et al.
Publicado: (2023)

The Fatty Liver, Cirrhosis, and Liver Cancer Study (TENDENCY): Protocol for a Multicenter Case-Control Study
por: Hussain, Yaqza, et al.
Publicado: (2023)

How Machine Perfusion Ameliorates Hepatic Ischaemia Reperfusion Injury
por: Clarke, George, et al.
Publicado: (2021)

Initial United Kingdom experience of endoscopic ultrasound-directed transgastric endoscopic retrograde cholangiopancreatography
por: Chhabra, Puneet, et al.
Publicado: (2022)

Editorial: Overcoming the Immune Microenvironment of Hepatocellular Cancer
por: Shetty, Shishir, et al.
Publicado: (2021)

Alleviation of Alcoholic Fatty Liver by Dendrobium officinale Flower Extracts due to Regulation of Gut Microbiota and Short-Chain Fatty Acids in Mice Exposed to Chronic Alcohol
por: Zhang, Jingchi, et al.
Publicado: (2023)

Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease
por: Tahir, Faryal, et al.
Publicado: (2020)

Prevalence of pulmonary disease in alcohol and poly substance abuse
por: Sheikh, Ghazanfar
Publicado: (2021)

Non-Parenchymal Cells and the Extracellular Matrix in Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease
por: van Son, Koen C., et al.
Publicado: (2023)

The Delivery of Multipotent Adult Progenitor Cells to Extended Criteria Human Donor Livers Using Normothermic Machine Perfusion
por: Laing, Richard W., et al.
Publicado: (2020)

Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers
por: Climax, John, et al.
Publicado: (2020)

An effective protocol for pharmacological defatting of primary human hepatocytes which is non-toxic to cholangiocytes or intrahepatic endothelial cells
por: Boteon, Yuri L., et al.
Publicado: (2018)

Mechanisms of autophagy activation in endothelial cell and their targeting during normothermic machine liver perfusion
por: Boteon, Yuri L, et al.
Publicado: (2017)

Increased ERCP volume improves cholangiogram interpretation: a new performance measure for ERCP training?
por: Vedantam, Shyam, et al.
Publicado: (2022)

A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease
por: Gray, Joe, et al.
Publicado: (2009)

A Switch in Hepatic Cortisol Metabolism across the Spectrum of Non Alcoholic Fatty Liver Disease
por: Ahmed, Adeeba, et al.
Publicado: (2012)

Understanding the Relationship between Atherogenic Index of Plasma and Cardiovascular Disease Risk Factors among Staff of an University in Malaysia
por: Bo, Myat Su, et al.
Publicado: (2018)

Macrophages and the development and progression of non-alcoholic fatty liver disease
por: Alabdulaali, Bader, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t725tj3nn5uu24c4lucpihu6gm